Health Catalyst Inc
$ 1.73
1.76%
24 Feb - close price
- Market Cap 120,242,000 USD
- Current Price $ 1.73
- High / Low $ 1.85 / 1.70
- Stock P/E N/A
- Book Value 4.70
- EPS -1.58
- Next Earning Report 2026-02-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.05 %
- ROE -0.31 %
- 52 Week High 5.09
- 52 Week Low 1.67
About
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$3.88
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-11 | 2025-08-07 | 2025-05-07 | 2025-02-20 | 2024-11-06 | 2024-08-07 | 2024-05-09 | 2024-02-22 | 2023-10-27 | 2023-08-08 | 2023-05-09 | 2023-02-28 |
| Reported EPS | 0.06 | -0.59 | 0.01 | 0.04 | 0.07 | 0.12 | 0.05 | 0.02 | 0.03 | 0.05 | 0.05 | -0.05 |
| Estimated EPS | 0.0629 | 0.04 | 0.03 | 0.0764 | 0.1 | 0.08 | 0.03 | -0.0002 | -0.02 | -0.02 | -0.04 | -0.11 |
| Surprise | -0.0029 | -0.63 | -0.02 | -0.0364 | -0.03 | 0.04 | 0.02 | 0.0202 | 0.05 | 0.07 | 0.09 | 0.06 |
| Surprise Percentage | -4.6105% | -1575% | -66.6667% | -47.644% | -30% | 50% | 66.6667% | 10100% | 250% | 350% | 225% | 54.5455% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-25 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.0 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HCAT
2026-02-19 12:28:47
Health Catalyst (NASDAQ:HCAT) has appointed Ben Albert as its new CEO and board member, effective February 12, 2026, succeeding Dan Burton. Albert, previously President and COO, joined the company through an acquisition and brings extensive healthcare leadership experience. The company also announced a reduction in its board size to five directors, with Justin Spencer elected as Board Chair, as part of strategic efforts to enhance operational depth and focus amidst its stock trading near a 52-week low.
2026-02-18 20:27:13
Health Catalyst (HCAT) has appointed Ben Albert as its new CEO and a member of its Board of Directors, effective February 12. Albert, previously President and COO, replaces Dan Burton, who will transition to a strategic advisor role. Albert's appointment follows his work to streamline the company's leadership and focus resources on key business priorities for improved financial performance.
2026-02-18 18:57:13
Health Catalyst, Inc. (NASDAQ:HCAT) has appointed Ben Albert as its new CEO and board member, effective February 12, 2026, as the company's stock trades near its 52-week low. Albert, previously President and COO, takes over from Dan Burton and plans to leverage his extensive healthcare experience to improve clinical quality and strengthen consumer loyalty. Concurrently, the healthcare data company announced a reduction in its board size from nine to five directors, with Justin Spencer elected as the new Board Chair.
2026-02-18 13:57:13
Health Catalyst (Nasdaq: HCAT) has appointed Ben Albert as its new Chief Executive Officer, effective February 12, 2026. Albert, previously the President and COO, will focus on improving cost and operational efficiency, clinical quality, and consumer experience. Former CEO Dan Burton has stepped down and will transition to a strategic advisor role, while the company's Board of Directors will be reduced to five members.
2026-02-18 08:57:44
Health Catalyst (NASDAQ:HCAT) is scheduled to release its Q4 2025 earnings before the market opens on Wednesday, February 25th, with analysts projecting earnings of $0.10 per share and revenue of $73.9880 million. The article also provides details on recent insider trading activities, institutional investor movements, and analyst ratings, alongside a company profile. The stock's price performance and key financial metrics are also outlined.
2026-02-18 04:57:44
A number of software stocks, including Zoom, Akamai Technologies, Health Catalyst, SentinelOne, and PubMatic, experienced a downturn due to investor fears that "agentic AI" tools could disrupt traditional Software-as-a-Service (SaaS) business models. This "AI Panic" led to a broad sell-off across the sector, although market overreactions can sometimes present buying opportunities for high-quality stocks. Health Catalyst, in particular, saw a significant drop, contributing to its year-to-date decline, amidst ongoing market volatility and shifting expectations for interest rate cuts from the Federal Reserve due to a strong U.S. jobs report.
